Reverse Auction: A Potential Strategy for Reduction of Pharmacological Therapy Cost. Brandão, S. M. G., Issa, V. S., Ayub-Ferreira, S. M., Storer, S., Gonçalves, B. G., Santos, V. G., Carvas Junior, N., Guimarães, G. V., & Bocchi, E. A. Arquivos Brasileiros de Cardiologia, 2015. ![Reverse Auction: A Potential Strategy for Reduction of Pharmacological Therapy Cost [link]](https://bibbase.org/img/filetypes/link.svg "link")
Paper doi abstract bibtex Background: Polypharmacy is a significant economic burden. Objective: We tested whether using reverse auction (RA) as compared with commercial pharmacy (CP) to purchase medicine results in lower pharmaceutical costs for heart failure (HF) and heart transplantation (HT) outpatients. Methods: We compared the costs via RA versus CP in 808 HF and 147 HT patients followed from 2009 through 2011, and evaluated the influence of clinical and demographic variables on cost. Results: The monthly cost per patient for HF drugs acquired via RA was $10.15 (IQ 3.51-40.22) versus $161.76 (IQ 86.05‑340.15) via CP; for HT, those costs were $393.08 (IQ 124.74-774.76) and $1,207.70 (IQ 604.48-2,499.97), respectively. Conclusions: RA may reduce the cost of prescription drugs for HF and HT, potentially making HF treatment more accessible. Clinical characteristics can influence the cost and benefits of RA. RA may be a new health policy strategy to reduce costs of prescribed medications for HF and HT patients, reducing the economic burden of treatment.(Arq Bras Cardiol. 2015; 105(3):265-275)
@article{brandao_reverse_2015-1,
title = {Reverse {Auction}: {A} {Potential} {Strategy} for {Reduction} of {Pharmacological} {Therapy} {Cost}},
issn = {0066-782X},
shorttitle = {Reverse {Auction}},
url = {http://www.gnresearch.org/doi/10.5935/abc.20150076},
doi = {10.5935/abc.20150076},
abstract = {Background: Polypharmacy is a significant economic burden. Objective: We tested whether using reverse auction (RA) as compared with commercial pharmacy (CP) to purchase medicine results in lower pharmaceutical costs for heart failure (HF) and heart transplantation (HT) outpatients. Methods: We compared the costs via RA versus CP in 808 HF and 147 HT patients followed from 2009 through 2011, and evaluated the influence of clinical and demographic variables on cost. Results: The monthly cost per patient for HF drugs acquired via RA was \$10.15 (IQ 3.51-40.22) versus \$161.76 (IQ 86.05‑340.15) via CP; for HT, those costs were \$393.08 (IQ 124.74-774.76) and \$1,207.70 (IQ 604.48-2,499.97), respectively. Conclusions: RA may reduce the cost of prescription drugs for HF and HT, potentially making HF treatment more accessible. Clinical characteristics can influence the cost and benefits of RA. RA may be a new health policy strategy to reduce costs of prescribed medications for HF and HT patients, reducing the economic burden of treatment.(Arq Bras Cardiol. 2015; 105(3):265-275)},
language = {en},
urldate = {2019-05-02},
journal = {Arquivos Brasileiros de Cardiologia},
author = {Brandão, Sara Michelly Gonçalves and Issa, Victor Sarli and Ayub-Ferreira, Silvia Moreira and Storer, Samantha and Gonçalves, Bianca Gigliotti and Santos, Valter Garcia and Carvas Junior, Nelson and Guimarães, Guilherme Veiga and Bocchi, Edimar Alcides},
year = {2015},
file = {Brandão et al. - 2015 - Reverse Auction A Potential Strategy for Reductio.pdf:/Users/neil.hawkins/Zotero/storage/FJCMRKII/Brandão et al. - 2015 - Reverse Auction A Potential Strategy for Reductio.pdf:application/pdf},
}
Downloads: 0
{"_id":"n2CfLWojumnhtivii","bibbaseid":"brando-issa-ayubferreira-storer-gonalves-santos-carvasjunior-guimares-etal-reverseauctionapotentialstrategyforreductionofpharmacologicaltherapycost-2015","author_short":["Brandão, S. M. G.","Issa, V. S.","Ayub-Ferreira, S. M.","Storer, S.","Gonçalves, B. G.","Santos, V. G.","Carvas Junior, N.","Guimarães, G. V.","Bocchi, E. A."],"bibdata":{"bibtype":"article","type":"article","title":"Reverse Auction: A Potential Strategy for Reduction of Pharmacological Therapy Cost","issn":"0066-782X","shorttitle":"Reverse Auction","url":"http://www.gnresearch.org/doi/10.5935/abc.20150076","doi":"10.5935/abc.20150076","abstract":"Background: Polypharmacy is a significant economic burden. Objective: We tested whether using reverse auction (RA) as compared with commercial pharmacy (CP) to purchase medicine results in lower pharmaceutical costs for heart failure (HF) and heart transplantation (HT) outpatients. Methods: We compared the costs via RA versus CP in 808 HF and 147 HT patients followed from 2009 through 2011, and evaluated the influence of clinical and demographic variables on cost. Results: The monthly cost per patient for HF drugs acquired via RA was $10.15 (IQ 3.51-40.22) versus $161.76 (IQ 86.05‑340.15) via CP; for HT, those costs were $393.08 (IQ 124.74-774.76) and $1,207.70 (IQ 604.48-2,499.97), respectively. Conclusions: RA may reduce the cost of prescription drugs for HF and HT, potentially making HF treatment more accessible. Clinical characteristics can influence the cost and benefits of RA. RA may be a new health policy strategy to reduce costs of prescribed medications for HF and HT patients, reducing the economic burden of treatment.(Arq Bras Cardiol. 2015; 105(3):265-275)","language":"en","urldate":"2019-05-02","journal":"Arquivos Brasileiros de Cardiologia","author":[{"propositions":[],"lastnames":["Brandão"],"firstnames":["Sara","Michelly","Gonçalves"],"suffixes":[]},{"propositions":[],"lastnames":["Issa"],"firstnames":["Victor","Sarli"],"suffixes":[]},{"propositions":[],"lastnames":["Ayub-Ferreira"],"firstnames":["Silvia","Moreira"],"suffixes":[]},{"propositions":[],"lastnames":["Storer"],"firstnames":["Samantha"],"suffixes":[]},{"propositions":[],"lastnames":["Gonçalves"],"firstnames":["Bianca","Gigliotti"],"suffixes":[]},{"propositions":[],"lastnames":["Santos"],"firstnames":["Valter","Garcia"],"suffixes":[]},{"propositions":[],"lastnames":["Carvas","Junior"],"firstnames":["Nelson"],"suffixes":[]},{"propositions":[],"lastnames":["Guimarães"],"firstnames":["Guilherme","Veiga"],"suffixes":[]},{"propositions":[],"lastnames":["Bocchi"],"firstnames":["Edimar","Alcides"],"suffixes":[]}],"year":"2015","file":"Brandão et al. - 2015 - Reverse Auction A Potential Strategy for Reductio.pdf:/Users/neil.hawkins/Zotero/storage/FJCMRKII/Brandão et al. - 2015 - Reverse Auction A Potential Strategy for Reductio.pdf:application/pdf","bibtex":"@article{brandao_reverse_2015-1,\n\ttitle = {Reverse {Auction}: {A} {Potential} {Strategy} for {Reduction} of {Pharmacological} {Therapy} {Cost}},\n\tissn = {0066-782X},\n\tshorttitle = {Reverse {Auction}},\n\turl = {http://www.gnresearch.org/doi/10.5935/abc.20150076},\n\tdoi = {10.5935/abc.20150076},\n\tabstract = {Background: Polypharmacy is a significant economic burden. Objective: We tested whether using reverse auction (RA) as compared with commercial pharmacy (CP) to purchase medicine results in lower pharmaceutical costs for heart failure (HF) and heart transplantation (HT) outpatients. Methods: We compared the costs via RA versus CP in 808 HF and 147 HT patients followed from 2009 through 2011, and evaluated the influence of clinical and demographic variables on cost. Results: The monthly cost per patient for HF drugs acquired via RA was \\$10.15 (IQ 3.51-40.22) versus \\$161.76 (IQ 86.05‑340.15) via CP; for HT, those costs were \\$393.08 (IQ 124.74-774.76) and \\$1,207.70 (IQ 604.48-2,499.97), respectively. Conclusions: RA may reduce the cost of prescription drugs for HF and HT, potentially making HF treatment more accessible. Clinical characteristics can influence the cost and benefits of RA. RA may be a new health policy strategy to reduce costs of prescribed medications for HF and HT patients, reducing the economic burden of treatment.(Arq Bras Cardiol. 2015; 105(3):265-275)},\n\tlanguage = {en},\n\turldate = {2019-05-02},\n\tjournal = {Arquivos Brasileiros de Cardiologia},\n\tauthor = {Brandão, Sara Michelly Gonçalves and Issa, Victor Sarli and Ayub-Ferreira, Silvia Moreira and Storer, Samantha and Gonçalves, Bianca Gigliotti and Santos, Valter Garcia and Carvas Junior, Nelson and Guimarães, Guilherme Veiga and Bocchi, Edimar Alcides},\n\tyear = {2015},\n\tfile = {Brandão et al. - 2015 - Reverse Auction A Potential Strategy for Reductio.pdf:/Users/neil.hawkins/Zotero/storage/FJCMRKII/Brandão et al. - 2015 - Reverse Auction A Potential Strategy for Reductio.pdf:application/pdf},\n}\n\n","author_short":["Brandão, S. M. G.","Issa, V. S.","Ayub-Ferreira, S. M.","Storer, S.","Gonçalves, B. G.","Santos, V. G.","Carvas Junior, N.","Guimarães, G. V.","Bocchi, E. A."],"bibbaseid":"brando-issa-ayubferreira-storer-gonalves-santos-carvasjunior-guimares-etal-reverseauctionapotentialstrategyforreductionofpharmacologicaltherapycost-2015","role":"author","urls":{"Paper":"http://www.gnresearch.org/doi/10.5935/abc.20150076"},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/f/FfNE7kWA6pCvwcJZF/myPubs.bib","dataSources":["ZaHtWavQhcwZqKLNF","iRRNaRs6FkffgErta","v8uQmZsBpiqycmskv"],"keywords":[],"search_terms":["reverse","auction","potential","strategy","reduction","pharmacological","therapy","cost","brandão","issa","ayub-ferreira","storer","gonçalves","santos","carvas junior","guimarães","bocchi"],"title":"Reverse Auction: A Potential Strategy for Reduction of Pharmacological Therapy Cost","year":2015}